Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial

BACKGROUND: Although lithium is considered the gold-standard treatment for bipolar disorder (BD), it is associated with a variety of major endocrine and metabolic side effects, including parathyroid hormone (PTH) dependent hypercalcemia. Aside from surgery and medication discontinuation, there are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Soh, Jocelyn Fotso, Bodenstein, Katie, Yu, Oriana Hoi Yun, Linnaranta, Outi, Renaud, Suzane, Mahdanian, Artin, Su, Chien-Lin, Mucsi, Istvan, Mulsant, Benoit, Herrmann, Nathan, Rajji, Tarek, Beaulieu, Serge, Sekhon, Harmehr, Rej, Soham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508741/
https://www.ncbi.nlm.nih.gov/pubmed/36153583
http://dx.doi.org/10.1186/s12902-022-01145-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508741/
https://www.ncbi.nlm.nih.gov/pubmed/36153583
http://dx.doi.org/10.1186/s12902-022-01145-w

Ejemplares similares